3 Ways Tomorrow’s AI Will Differ From Today’s Chatbots
In an interview, OpenAI’s CEO Sam Altman discusses job disruption, data and the ‘person-ness’ of bots.
Energy & Utilities Roundup: Market Talk
Shell and TotalEnergies and more in the latest Market Talks covering Energy and Utilities.
Health Care Roundup: Market Talk
Roche Holding, Bristol Myers and more in the latest Market Talks covering the Health Care sector.
Basic Materials Roundup: Market Talk
Mondi, Centamin and more in the latest Market Talks covering Basic Materials.
Tech, Media & Telecom Roundup: Market Talk
Netflix, Crown Castle and more in the latest Market Talks covering Technology, Media and Telecom.
Financial Services Roundup: Market Talk
Man Group, Bank of Nova Scotia and more in the latest Market Talks covering Financial Services.
Israel Evacuates City Near Lebanon Border as It Hits Scores of Targets in Gaza
The decision to move residents of Kiryat Shmona, a city of some 22,000 people, reflects Israeli concern over a second front opening […]
Even Lionel Messi Couldn’t Save a Doomed American Season
After the Argentine superstar failed to rescue Inter Miami’s league campaign, questions surfaced about how he might spend the offseason.
Ozempic Boom Is an Opportunity for Health Insurers
Demand for GLP-1 weight loss drugs could be a net positive for insurance companies with pharmacy-benefit businesses.
Ukraine Targets Russia’s Big Guns to Blast a Path Forward
Ukraine has honed its systems for finding and destroying Russian artillery. But Russia is also adapting.
The Next Hot Obesity Drug Won’t Be Approved for Years. Online Sellers Hawk It Anyway.
Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound.
Jordan Set to Fall Short in Third Speaker Vote
The Republican nominee has struggled to win support from colleagues who have opposed his candidacy, likely leaving the party at a fresh […]